BioWorld

Oct. 13, 2006

View Archived Issues

Genzyme, Now In Front For AnorMED, Reports Earnings

Genzyme Corp., which has moved to the forefront of a bidding war for AnorMED Inc., on Thursday reported third-quarter earnings that came out ahead of consensus projections but nonetheless failed to impress many observers. (BioWorld Today) Read More

Amyris Venture Round Gets $20M For Microbe Synthesis

Read More

New Study Reveals Depths Of Ignorance On Cloning Basics

Read More

Ambrilia Sells HIV Product To Merck For Up To $232M

Read More

Clinic Roundup

Read More

Other News To Note

Read More